165 related articles for article (PubMed ID: 30321376)
1. Site specific target binding controls RNA cleavage efficiency by the Kaposi's sarcoma-associated herpesvirus endonuclease SOX.
Mendez AS; Vogt C; Bohne J; Glaunsinger BA
Nucleic Acids Res; 2018 Dec; 46(22):11968-11979. PubMed ID: 30321376
[TBL] [Abstract][Full Text] [Related]
2. C19ORF66 Broadly Escapes Virus-Induced Endonuclease Cleavage and Restricts Kaposi's Sarcoma-Associated Herpesvirus.
Rodriguez W; Srivastav K; Muller M
J Virol; 2019 Jun; 93(12):. PubMed ID: 30944177
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome-Wide Cleavage Site Mapping on Cellular mRNAs Reveals Features Underlying Sequence-Specific Cleavage by the Viral Ribonuclease SOX.
Gaglia MM; Rycroft CH; Glaunsinger BA
PLoS Pathog; 2015 Dec; 11(12):e1005305. PubMed ID: 26646420
[TBL] [Abstract][Full Text] [Related]
4. A ribonucleoprotein complex protects the interleukin-6 mRNA from degradation by distinct herpesviral endonucleases.
Muller M; Hutin S; Marigold O; Li KH; Burlingame A; Glaunsinger BA
PLoS Pathog; 2015 May; 11(5):e1004899. PubMed ID: 25965334
[TBL] [Abstract][Full Text] [Related]
5. An RNA element in human interleukin 6 confers escape from degradation by the gammaherpesvirus SOX protein.
Hutin S; Lee Y; Glaunsinger BA
J Virol; 2013 Apr; 87(8):4672-82. PubMed ID: 23408619
[TBL] [Abstract][Full Text] [Related]
6. Virus-encoded endonucleases: expected and novel functions.
Read GS
Wiley Interdiscip Rev RNA; 2013; 4(6):693-708. PubMed ID: 23900973
[TBL] [Abstract][Full Text] [Related]
7. The m
Macveigh-Fierro D; Cicerchia A; Cadorette A; Sharma V; Muller M
Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35177478
[TBL] [Abstract][Full Text] [Related]
8. Nuclease escape elements protect messenger RNA against cleavage by multiple viral endonucleases.
Muller M; Glaunsinger BA
PLoS Pathog; 2017 Aug; 13(8):e1006593. PubMed ID: 28841715
[TBL] [Abstract][Full Text] [Related]
9. The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable.
Glaunsinger B; Chavez L; Ganem D
J Virol; 2005 Jun; 79(12):7396-401. PubMed ID: 15919895
[TBL] [Abstract][Full Text] [Related]
10. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction.
Lee YJ; Glaunsinger BA
PLoS Biol; 2009 May; 7(5):e1000107. PubMed ID: 19468299
[TBL] [Abstract][Full Text] [Related]
11. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus.
Conrad NK
Adv Appl Microbiol; 2009; 68():241-61. PubMed ID: 19426857
[TBL] [Abstract][Full Text] [Related]
12. Structure of the Open Reading Frame 49 Protein Encoded by Kaposi's Sarcoma-Associated Herpesvirus.
Hew K; Veerappan S; Sim D; Cornvik T; Nordlund P; Dahlroth SL
J Virol; 2017 Jan; 91(2):. PubMed ID: 27807232
[TBL] [Abstract][Full Text] [Related]
13. Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA.
Liu D; Wang Y; Yuan Y
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321307
[TBL] [Abstract][Full Text] [Related]
14. Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.
Verma D; Li DJ; Krueger B; Renne R; Swaminathan S
J Virol; 2015 Feb; 89(3):1688-702. PubMed ID: 25410858
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands.
Miller JT; Zhao H; Masaoka T; Varnado B; Cornejo Castro EM; Marshall VA; Kouhestani K; Lynn AY; Aron KE; Xia A; Beutler JA; Hirsch DR; Tang L; Whitby D; Murelli RP; Le Grice SFJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30061278
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's Sarcoma-Associated Herpesvirus Hijacks RNA Polymerase II To Create a Viral Transcriptional Factory.
Chen CP; Lyu Y; Chuang F; Nakano K; Izumiya C; Jin D; Campbell M; Izumiya Y
J Virol; 2017 Jun; 91(11):. PubMed ID: 28331082
[TBL] [Abstract][Full Text] [Related]
18. RNA decay during gammaherpesvirus infection reduces RNA polymerase II occupancy of host promoters but spares viral promoters.
Hartenian E; Gilbertson S; Federspiel JD; Cristea IM; Glaunsinger BA
PLoS Pathog; 2020 Feb; 16(2):e1008269. PubMed ID: 32032393
[TBL] [Abstract][Full Text] [Related]
19. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's sarcoma-associated herpesvirus ORF57 protein enhances mRNA accumulation independently of effects on nuclear RNA export.
Nekorchuk M; Han Z; Hsieh TT; Swaminathan S
J Virol; 2007 Sep; 81(18):9990-8. PubMed ID: 17609285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
